About 12 results found for searched term "Bcl-2" (0.417 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M13532 | S55746 | Bcl-2 |
| BCL201 | ||
| S55746 (BCL201) is a potent, orally active and selective BCL-2 inhibitor, with a Ki of 1.3 nM and a Kd of 3.9 nM. S55746 (BCL201) has antitumor activity with low toxicity. | ||
| M13533 | S55746 hydrochloride | Bcl-2 |
| BCL201 hydrochloride | ||
| S55746 hydrochloride (BCL201 hydrochloride) is a potent, orally active and selective BCL-2 inhibitor, with a Ki of 1.3 nM and a Kd of 3.9 nM. S55746 hydrochloride (BCL201 hydrochloride) has antitumor activity with low toxicity. | ||
| M22479 | Lisaftoclax | Bcl-2 |
| APG-2575; Bcl-2/Bcl-xl inhibitor 1 | ||
| Lisaftoclax (APG-2575) is a dual Bcl-2 and Bcl-xl inhibitor with anti-tumor activity, exhibits IC50 values of 2 nM and 5.9 nM for Bcl-2 and Bcl-xl, respectively. | ||
| M28068 | A-1211212 | Bcl-2 |
| BCL2-IN-1 | ||
| A-1211212 (BCL2-IN-1) is a potent Bcl-2 inhibitor. BCL2-IN-1 binds Bcl-2 with a Ki of <0.01 nM. | ||
| M29577 | PROTAC Bcl2 degrader-1 | PROTAC |
| PROTAC Bcl2 degrader-1 (Compound C5) is a PROTAC based on Cereblon ligand, which potently and selectively induces the degradation of Bcl-2 (IC50, 4.94 μM; DC50, 3.0 μM) and Mcl-1 (IC50, 11.81 μM) by introducing the E3 ligase cereblon (CRBN)-binding ligand pomalidomide to Mcl-1/Bcl-2 dual inhibitor Nap-1. | ||
| M41317 | Bcl-2-IN-11 | Bcl-2 |
| Bcl-2-IN-11 is a potent and selective Bcl-2 activity inhibitor, with an IC50 of 0.9 nM. | ||
| M41436 | CDK2/Bcl2-IN-1 | CDK |
| CDK2/Bcl2-IN-1 with promising cytotoxicity against cancer cells. | ||
| M58115 | Recombinant Human Bcl-2 Protein (E. coli, C-His) | Cytokines and Growth Factors |
| B-cell leukemia/lymphoma 2 | ||
| B-cell leukemia/lymphoma 2, also known as Bcl-2, belongs to the Bcl-2 family. BCL2 blocks the apoptotic death of some cells such as lymphocytes. It also regulates cell death by controlling the mitochondrial membrane permeability and inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor. | ||
| M62151 | BCL2A1 Human Pre-designed siRNA Set | siRNA |
| Human BCL2A1 Pre-designed siRNA Set contains three designed siRNAs for BCL2A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Gene ID: 597 | ||
| M63210 | Bcl2 Mouse Pre-designed siRNA Set | siRNA |
| Mouse Bcl2 Pre-designed siRNA Set contains three designed siRNAs for Bcl2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control. Gene ID: 12043 | ||
| M63865 | BCL2L1 Mouse Pre-designed siRNA Set | siRNA |
| Mouse BCL2L1 Pre-designed siRNA Set contains three designed siRNAs for BCL2L1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control. Gene ID: 12048 | ||
| M65003 | BCL2 Human Pre-designed siRNA Set | siRNA |
| Human BCL2 Pre-designed siRNA Set contains three designed siRNAs for BCL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Gene ID: 596 | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
